Interim Report January - March 2015
STRONG GROWTH AND 6 XPS™ DELIVEREDFIRST QUARTER 2015 (JAN – MAR) • Net sales in the quarter amounted to SEK 31.8 (18.3) million, corresponding to an increase of 74 percent.• Operating income before depreciation and amortization (EBITDA) excluding one-time expenses amounted to SEK 4.5 (3.9) million, corresponding to an EBITDA margin of 14 percent. One-time expenses of SEK 1.7 (0.8) million related to the dispute regarding three Vivoline patents/patent applications have been charged against the quarter. Operating income before depreciation and amortization (EBITDA) amounted to SEK 2.8 (3.